Botanical Drug Market Revenue 2024 to 2034

Botanical Drug Market Revenue 2024 to 2034

The botanical drug market, valued at USD 37.5 billion in 2024, is forecasted to reach USD 61.08 billion by 2034, growing at 5% CAGR, driven by rising demand for plant-based therapeutics.

Report ID: 10455 | Format: Databook | Published: August 2025 | Delivery: Immediate
Download Sample     Customisation Request  

Revenue,

USD 37.50 Bn

Forecast Year,

USD 61.08 Bn

CAGR, 2025 -

5.00%

Report Coverage

Worldwide

Reviewed By

Aditi Shivarkar

Reviewed By

Aman Singh

Botanical Drug Market Size Analysis

Botanical Drug Market Size By Type 2024 to 2034 (USD )

Type 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033 2034
Prescription (Rx)23.1324.0525.3226.6627.6228.7231.1032.3133.8735.9938.09
OTC14.3715.3316.0216.7517.9719.1419.1620.4621.5322.1922.99

Botanical Drug Market Size By Application 2024 to 2034 (USD )

Application 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033 2034
Cardiovascular3.904.885.005.475.895.563.874.575.355.473.81
Oncology7.047.507.397.517.869.4210.6810.8412.1712.7312.81
Respiratory12.3012.7313.1513.3514.4814.3714.8916.3416.1217.9319.64
Neurology9.769.7511.1912.0511.4112.0514.7815.9417.1217.8917.65
Other4.494.524.615.035.946.456.045.084.654.167.17

Botanical Drug Market Size By Source 2024 to 2034 (USD )

Source 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033 2034
Herbal Extracts11.0911.6611.2213.0413.8613.6014.2914.5014.9115.5915.46
Complex Botanicals2.012.684.464.503.504.444.795.825.525.295.57
Others24.3925.0425.6625.8728.2229.8231.1732.4534.9737.2940.05

Botanical Drug Market Size By Region 2024 to 2034 (USD )

Region 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033 2034
North America6.055.435.444.444.115.885.745.335.205.106.00
Europe8.509.129.189.9210.119.619.8310.1812.6913.9215.76
Asia Pacific12.5713.8613.4114.8617.3117.6319.9923.7324.2424.9525.98
Latin America4.565.066.265.514.415.744.684.045.115.965.29
Middle East & Africa5.825.917.058.689.649.0010.019.498.168.238.07

Botanical Drug Market

Botanical Drug Market

Our Client